CLINDAMYCIN phosphate, eq. 150mg base/ml, 2ml, amp.
                    STD
                    DINJCLIN3A-
                
                Valid Article
                            Account code:
                            60000
                        
                        
                            HS Code:
                            300420
                        
                        
                            Last Updated on:
                            30/10/2025, 22:56:27
                        
                    
                Former
                    Code(s):
                     -X
                
            
            
                                    18
                            
                Shelf life = length of time a product can remain active and effective. 
Short shelf life = shelf life = < 24 months
            
                            
                            
                Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
            
            
                                    J01FF01
                            
                Anatomical Therapeutic Chemical Classification according to WHOCC
            
                            
                            
                Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
            
                    CLINDAMYCIN
Therapeutic Action
Lincosamide antibacterial
Indications
Second-line treatment of severe staphylococcal and/or streptococcal infections
Necrotising skin and soft tissues infections, severe cutaneous anthrax
Prophylaxis of post-operative infections in surgery
- See: Essential drugs, MSF, 2024
- See: Clinical guidelines, MSF, 2024
- See: Antibiotic prophylaxis for non-trauma and trauma surgical procedures. MSF internal protocol, 2019
- See: Pathogen-Specific, Targeted Antibiotic Therapy for Bacteremia and Bone and Joint, Urinary Tract, and Central Nervous System Infections. MSF internal protocol, 2019
- See: Neonatal care, Clinical and Therapeutic guidelines, MSF, 2021
Instructions for use
Dilute in 5% dextrose or 0.9% NaCl.
Must be given as IV infusion over 30 min.
Formulations without benzyl alcohol are preferred for paediatric use.
Precautions for Use
Do not administer by direct IV route without prior dilution.
Storage
- Below 25°C - Protect from sunlight
- Shelf-life: 18 to 24 months depending on the manufacturer. Refer to the manufacturer's packaging,
- After dilution, use the solution immediately.
 
                        